|
MechanismSARS-CoV-2 S protein inhibitors [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismRespiratory syncytial virus F protein inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with IDBiologics, Inc.
0 Patents (Medical) associated with IDBiologics, Inc.
100 Deals associated with IDBiologics, Inc.
100 Translational Medicine associated with IDBiologics, Inc.